A carregar...
Novel type I interferon IL-28A suppresses hepatitis C viral RNA replication
Interferon alpha (IFN-α)-based therapy is the currently approved treatment for chronic hepatitis C viral infection. The sustained antiviral response rate is approximately 50% for genotype-1 infection. The major challenge to the HCV community is to improve antiviral efficacy and to reduce the side ef...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2005
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1232870/ https://ncbi.nlm.nih.gov/pubmed/16146571 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1743-422X-2-80 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|